Literature DB >> 2905185

Amino acid pharmacology in neocortical slices: evidence for bimolecular actions from an extension of the Hill and Gaddum-Schild equations.

T L Williams1, D A Smith, N R Burton, T W Stone.   

Abstract

1. The equivalent circuit of the cortical slice preparation has been analysed to show that the measured d.c. voltages can be used to estimate the Hill coefficient for ligands acting on the pyramidal cell bodies. 2. The Gaddum-Schild equation for agonist-antagonist interactions has been modified for applications in which the Hill coefficient is not equal to 1. 3. The equations obtained have been applied to recent data of Burton et al. (1988). The results provide evidence for a bimolecular action of the agonists N-methyl-D-aspartate (NMDA) and quinolinic acid and the antagonists kynurenic acid and 2-amino-5-phosphono-pentanoic acid at NMDA receptors on mouse neocortical pyramidal cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2905185      PMCID: PMC1854217          DOI: 10.1111/j.1476-5381.1988.tb11708.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  The reaction between acetyl choline and muscle cells.

Authors:  A J Clark
Journal:  J Physiol       Date:  1926-08-06       Impact factor: 5.182

2.  The action of adrenalin and ergotamine on the uterus of the rabbit.

Authors:  J H Gaddum
Journal:  J Physiol       Date:  1926-03-18       Impact factor: 5.182

3.  Specific antagonism of excitant amino acids in the isolated spinal cord of the neonatal rat.

Authors:  R H Evans; J C Watkins
Journal:  Eur J Pharmacol       Date:  1978-07-15       Impact factor: 4.432

4.  Drug receptors and their function.

Authors:  H P Rang
Journal:  Nature       Date:  1971-05-14       Impact factor: 49.962

Review 5.  NMDA receptors and ligands in the vertebrate CNS.

Authors:  T W Stone; N R Burton
Journal:  Prog Neurobiol       Date:  1988       Impact factor: 11.685

Review 6.  Quinolinic acid and other kynurenines in the central nervous system.

Authors:  T W Stone; J H Connick
Journal:  Neuroscience       Date:  1985-07       Impact factor: 3.590

7.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

8.  Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex.

Authors:  N L Harrison; M A Simmonds
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

9.  A quantitative pharmacological analysis of some excitatory amino acid receptors in the mouse neocortex in vitro.

Authors:  N R Burton; D A Smith; T W Stone
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

  9 in total
  7 in total

1.  In vitro characterization of prostanoid EP-receptors in the non-pregnant human myometrium.

Authors:  J Senior; K Marshall; R Sangha; G S Baxter; J K Clayton
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

2.  Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein.

Authors:  R A Lawrence; R L Jones
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

3.  An EP receptor with a novel pharmacological profile in the T-cell line Jurkat.

Authors:  G W De Vries; P Guarino; A McLaughlin; J Chen; S Andrews; D F Woodward
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

4.  In vitro characterization of prostanoid receptors on human myometrium at term pregnancy.

Authors:  J Senior; K Marshall; R Sangha; J K Clayton
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

5.  Characterization of the prostanoid receptors mediating constriction and relaxation of human isolated uterine artery.

Authors:  G S Baxter; J K Clayton; R A Coleman; K Marshall; R Sangha; J Senior
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

6.  Prejunctional prostanoid receptors on cardiac adrenergic terminals belong to the EP3 subtype.

Authors:  L Mantelli; S Amerini; A Rubino; F Ledda
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

Review 7.  Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson's Disease?

Authors:  Keerthi Thirtamara-Rajamani; Peipei Li; Martha L Escobar Galvis; Viviane Labrie; Patrik Brundin; Lena Brundin
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.